Paul-Joël Derian

Title: Paul-Joël Derian: Innovator in Pharmaceutical Compositions

Introduction

Paul-Joël Derian is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release tablet formulations. His innovative work has led to the granting of a patent that showcases his expertise and dedication to improving drug delivery systems.

Latest Patents

Paul-Joël Derian holds a patent for "Pharmaceutical compositions in the form of sustained-release tablets based on high molecular weight polysaccharide granules." This invention relates to a delayed-release pharmaceutical composition that is prepared by direct tableting. The composition consists of at least one active principle and a matrix that provides the delayed-release effect. The matrix is characterized by its inclusion of pregranulated polysaccharides of high molecular weight, which can be of synthetic or natural origin. This advancement in pharmaceutical technology aims to enhance the efficacy and patient compliance of medications.

Career Highlights

Throughout his career, Paul-Joël Derian has been associated with Rhodia Chimie, a company known for its innovative chemical solutions. His work at Rhodia Chimie has allowed him to collaborate with other talented professionals in the field, furthering the development of effective pharmaceutical products.

Collaborations

Some of his notable coworkers include Jean-Pierre Collaueri and Guillaume Conrath. Their collaborative efforts have contributed to the success of various projects within the company, fostering an environment of innovation and creativity.

Conclusion

Paul-Joël Derian's contributions to the pharmaceutical industry through his patent and work at Rhodia Chimie highlight his role as an innovator. His dedication to developing advanced drug delivery systems continues to impact the field positively.